Generation Bio Co. (GBIO)
NASDAQ: GBIO · Real-Time Price · USD
2.515
-0.015 (-0.59%)
Sep 13, 2024, 10:08 AM EDT - Market open
Generation Bio Co. Market Cap
Generation Bio Co. has a market cap or net worth of $167.85 million as of September 13, 2024. Its market cap has decreased by -52.50% in one year.
Market Cap
167.85M
Enterprise Value
45.87M
1-Year Change
-52.50%
Ranking
Category
Stock Price
$2.52
Market Cap Chart
Since June 12, 2020, Generation Bio Co.'s market cap has decreased from $1.09B to $167.85M, a decrease of -84.59%. That is a compound annual growth rate of -35.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2024 | 168.90M | 54.95% |
| Dec 29, 2023 | 109.00M | -53.32% |
| Dec 30, 2022 | 233.50M | -42.05% |
| Dec 31, 2021 | 402.90M | -69.45% |
| Dec 31, 2020 | 1.32B | 21.09% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| High Tide | 176.85M |
| Compugen | 176.39M |
| TruBridge | 175.95M |
| Inovio Pharmaceuticals | 175.21M |
| Telomir Pharmaceuticals | 174.70M |
| Amylyx Pharmaceuticals | 172.93M |
| CVRx, Inc. | 172.32M |
| Galectin Therapeutics | 171.89M |